- Home
- RARE vs CWT Comparison
RARE vs CWT Comparison
Compare RARE & CWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RARE
- CWT
- Stock Information
- Founded
- RARE 2010
- CWT 1926
- Country
- RARE United States
- CWT United States
- Employees
- RARE N/A
- CWT N/A
- Industry
- RARE Biotechnology: Pharmaceutical Preparations
- CWT Water Supply
- Sector
- RARE Health Care
- CWT Utilities
- Exchange
- RARE Nasdaq
- CWT Nasdaq
- Market Cap
- RARE 3.3B
- CWT 3.0B
- IPO Year
- RARE 2014
- CWT N/A
- Fundamental
- Price
- RARE $37.17
- CWT $45.61
- Analyst Decision
- RARE Strong Buy
- CWT Strong Buy
- Analyst Count
- RARE 17
- CWT 2
- Target Price
- RARE $92.29
- CWT $56.50
- AVG Volume (30 Days)
- RARE 974.0K
- CWT 323.9K
- Earning Date
- RARE 07-31-2025
- CWT 07-31-2025
- Dividend Yield
- RARE N/A
- CWT 2.63%
- EPS Growth
- RARE N/A
- CWT N/A
- EPS
- RARE N/A
- CWT 2.26
- Revenue
- RARE $590,689,000.00
- CWT $970,030,000.00
- Revenue This Year
- RARE $18.94
- CWT N/A
- Revenue Next Year
- RARE $28.93
- CWT $7.46
- P/E Ratio
- RARE N/A
- CWT $20.15
- Revenue Growth
- RARE 33.46
- CWT 3.83
- 52 Week Low
- RARE $29.59
- CWT $41.64
- 52 Week High
- RARE $60.37
- CWT $56.25
- Technical
- Relative Strength Index (RSI)
- RARE 55.64
- CWT 38.34
- Support Level
- RARE $35.73
- CWT $46.20
- Resistance Level
- RARE $36.22
- CWT $47.53
- Average True Range (ATR)
- RARE 1.37
- CWT 0.80
- MACD
- RARE 0.25
- CWT -0.10
- Stochastic Oscillator
- RARE 90.54
- CWT 5.44
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About CWT California Water Service Group
California Water Service Group is a U.S. water and utilities holding company based in California. The company engages in the production, treatment, storage, distribution, and sale of water for various uses. The firm operates through its subsidiaries, which can be divided between regulated and unregulated businesses. The regulated public utilities subsidiaries operate in California, New Mexico, Washington, and Hawaii. The unregulated subsidiaries provide water utility services to private companies and municipalities. The company derives the majority of its revenue from its operations in California and, overall, from residential customers.